In this EURETINA IME video series on dry AMD and GA, Prof. Frank G. Holz and Dr. Arshad Khanani explore promising new treatments targeting the complement pathway for geographic atrophy. They discuss how to select appropriate patients and integrate these emerging therapies into clinical workflows, ensuring a smooth experience for both practitioners and patients.

Prof. Holz and Dr. Khanani also emphasize the importance of clear communication about potential side effects, as well as rare adverse events, offering strategies to help avoid or manage them effectively. Drawing from real-world experience, they provide valuable insights on optimizing the use of these therapies.

Be sure to check out the other two videos in this series for a comprehensive look at dry AMD and GA!

Independent Medical Education supported by Apellis and Astellas Pharma.